Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.
Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW Jr, Sowder RC 2nd, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE.
J Virol. 2006 Sep;80(18):9039-52.
Related citations
The role of viral and cellular proteins in the budding of human immunodeficiency virus.
Mazzé FM, Degrève L.
Acta Virol. 2006;50(2):75-85. Review.
Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.
Harila K, Prior I, Sjöberg M, Salminen A, Hinkula J, Suomalainen M.
J Virol. 2006 Apr;80(8):3765-72.
Variability in the P6gag domains of HIV-1 involved in viral budding.
Holguín A, Alvarez A, Soriano V.
AIDS. 2006 Feb 28;20(4):624-7.
Solution structure of the human immunodeficiency virus type 1 p6 protein.
Fossen T, Wray V, Bruns K, Rachmat J, Henklein P, Tessmer U, Maczurek A, Klinger P, Schubert U.
J Biol Chem. 2005 Dec 30;280(52):42515-27. Epub 2005 Oct 17.
The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.
Medina G, Zhang Y, Tang Y, Gottwein E, Vana ML, Bouamr F, Leis J, Carter CA.
Traffic. 2005 Oct;6(10):880-94.
Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infection.
Colgrove RC, Millet A, Bauer GR, Pitt J, Welles SL.
AIDS Res Hum Retroviruses. 2005 Mar;21(3):191-9.
A bipartite late-budding domain in human immunodeficiency virus type 1.
Martin-Serrano J, Bieniasz PD.
J Virol. 2003 Nov;77(22):12373-7.
Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release.
Goff A, Ehrlich LS, Cohen SN, Carter CA.
J Virol. 2003 Sep;77(17):9173-82.
Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.
Goila-Gaur R, Demirov DG, Orenstein JM, Ono A, Freed EO.
J Virol. 2003 Jun;77(11):6507-19.
Role of ESCRT-I in retroviral budding.
Martin-Serrano J, Zang T, Bieniasz PD.
J Virol. 2003 Apr;77(8):4794-804.
The HIV-TSG101 interface: recent advances in a budding field.
Freed EO.
Trends Microbiol. 2003 Feb;11(2):56-9.
Tsg101, an inactive homologue of ubiquitin ligase e2, interacts specifically with human immunodeficiency virus type 2 gag polyprotein and results in increased levels of ubiquitinated gag.
Myers EL, Allen JF.
J Virol. 2002 Nov;76(22):11226-35.
Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein.
Pornillos O, Alam SL, Davis DR, Sundquist WI.
Nat Struct Biol. 2002 Nov;9(11):812-7.
Structure and functional interactions of the Tsg101 UEV domain.
Pornillos O, Alam SL, Rich RL, Myszka DG, Davis DR, Sundquist WI.
EMBO J. 2002 May 15;21(10):2397-406.
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
Demirov DG, Ono A, Orenstein JM, Freed EO.
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60.
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
Nat Med. 2001 Dec;7(12):1313-9.
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.
Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Côté M, Rich RL, Myszka DG, Sundquist WI.
Cell. 2001 Oct 5;107(1):55-65.
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).
VerPlank L, Bouamr F, LaGrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA.
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9. Epub 2001 Jun 26.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on